Amlogenyx Inc. (Seed)

Funding Details

Awarder

RSS - feed.businesswire.com

Date Award

August 02, 2024

Vertical

Biopharmaceuticals

Funding URL

View Funding Page

Funding Amount:

$14,000,000

---

Company Info

Founding Year

2021

Organizations Involved

St. Jude Children’s Research Hospital

Founders

Emil Kakkis, M.D., Ph.D.

Company Description

Amlogenyx, a subsidiary of Ultragenyx Pharmaceutical, Inc., is researching and developing novel gene therapies for Alzheimer’s disease and other amyloid diseases.

Market

Alzheimer's Disease and Amyloid Diseases

Location

Beverly Hills, CA, US

Coinvestors

Ultragenyx Pharmaceutical, Inc.

---

Links

• Website